Found 461 chains in Knotted chains table. Displaying 1 - 150. Applied filters: Probabilistic

Search results query: topological notation: S +31 3x +31

Hide raw data panel 
#pdbid|chain|deposition date|is S/K-not|(slip)knot types;
      
  6ymb|A|2020-08-23|S|+3.1;
  6ufd|A|2020-08-22|S|+3.1;
  6ufb|A|2020-08-22|S|+3.1;
  6ufc|A|2020-08-22|S|+3.1;
  6klz|A|2020-08-20|S|+3.1;
  6km0|A|2020-08-20|S|+3.1;
  6km4|A|2020-08-20|S|+3.1;
  6km6|A|2020-08-20|S|+3.1;
  6wq4|A|2020-08-06|S|+3.1;
  6wq8|A|2020-08-06|S|+3.1;
  6wq9|A|2020-08-06|S|+3.1;
  6t7u|A|2020-08-05|S|+3.1;
  6t9z|A|2020-08-05|S|+3.1;
  6rmx|A|2020-08-05|S|+3.1;
  6otk|A|2020-08-04|S|+3.1;
  6oto|A|2020-08-04|S|+3.1;
  6otq|A|2020-08-04|S|+3.1;
  6oub|A|2020-08-04|S|+3.1;
  6otp|A|2020-08-04|S|+3.1;
  6ouh|A|2020-08-04|S|+3.1;
  6oud|A|2020-08-04|S|+3.1;
  6ouf|A|2020-08-04|S|+3.1;
  6ouk|A|2020-08-04|S|+3.1;
  6oui|A|2020-08-04|S|+3.1;
  6ouj|A|2020-08-04|S|+3.1;
  6oum|A|2020-08-04|S|+3.1;
  6rg3|A|2020-08-04|S|+3.1;
  6rmy|A|2020-08-04|S|+3.1;
  6rhk|A|2020-08-04|S|+3.1;
  6rzx|A|2020-08-04|S|+3.1;
  6s03|A|2020-08-04|S|+3.1;
  6sds|A|2020-08-04|S|+3.1;
  6r6j|A|2020-04-17|S|+3.1;
  6r71|A|2020-04-17|S|+3.1;
  6rm1|A|2020-04-17|S|+3.1;
  6qut|A|2020-04-07|S|+3.1;
  6vkg|A|2020-04-02|S|+3.1;
  6ugp|A|2020-03-31|S|+3.1;
  6ugq|A|2020-03-31|S|+3.1;
  6ugr|A|2020-03-31|S|+3.1;
  6ugz|A|2020-03-31|S|+3.1;
  6ugo|A|2020-03-31|S|+3.1;
  6uh0|A|2020-03-31|S|+3.1;
  6r6f|A|2020-03-30|S|+3.1;
  6qn0|A|2020-03-08|S|+3.1;
  6qn2|A|2020-03-08|S|+3.1;
  6qn6|A|2020-03-08|S|+3.1;
  6u4q|A|2020-01-29|S|+3.1;
  6u4t|A|2020-01-29|S|+3.1;
  6nm0|A|2020-01-22|S|+3.1;
  6nlv|A|2020-01-22|S|+3.1;
  6i0l|A|2019-11-27|S|+3.1;
  6nj3|A|2019-10-17|S|+3.1;
  6nj6|A|2019-10-17|S|+3.1;
  6ql2|A|2019-10-16|S|+3.1;
  6ql1|A|2019-10-16|S|+3.1;
  6hd2|A|2019-09-11|S|+3.1;
  6gxb|A|2019-05-15|S|+3.1;
  6gxe|A|2019-05-15|S|+3.1;
  6qfw|A|2019-04-25|S|+3.1;
  6qfu|A|2019-04-25|S|+3.1;
  6qfv|A|2019-04-25|S|+3.1;
  6qfx|A|2019-04-25|S|+3.1;
  6mby|A|2019-03-20|S|+3.1;
  6g6t|A|2019-03-20|S|+3.1;
  6g5u|A|2019-03-20|S|+3.1;
  6g5l|A|2019-03-20|S|+3.1;
  6g7a|A|2019-03-20|S|+3.1;
  6mbv|A|2019-03-20|S|+3.1;
  6qeb|A|2019-03-08|S|+3.1;
  6fjj|A|2019-03-06|S|+3.1;
  6fji|A|2019-03-06|S|+3.1;
  6gcy|A|2019-03-06|S|+3.1;
  6h6s|A|2019-01-16|S|+3.1;
  6hwz|A|2019-01-09|S|+3.1;
  6hx5|A|2019-01-09|S|+3.1;
  6h33|A|2019-01-08|S|+3.1;
  6h34|A|2019-01-08|S|+3.1;
  6g3q|A|2018-12-02|S|+3.1;
  6g3v|A|2018-12-02|S|+3.1;
  6eeo|A|2018-12-02|S|+3.1;
  6ecz|A|2018-12-02|S|+3.1;
  6eeh|A|2018-12-02|S|+3.1;
  6ebe|A|2018-12-02|S|+3.1;
  4ygl|A|2018-10-21|S|+3.1;
  1ttm|A|2018-10-21|S|+3.1;
  1azm|A|2018-10-21|S|+3.1;
  5nea|A|2018-10-21|S|+3.1;
  6b59|A|2018-10-21|S|+3.1;
  5e2m|A|2018-10-21|S|+3.1;
  4qsj|A|2018-10-21|S|+3.1;
  1rzb|A|2018-10-21|S|+3.1;
  5ohh|A|2018-10-21|S|+3.1;
  5n25|A|2018-10-21|S|+3.1;
  4qiz|A|2018-10-21|S|+3.1;
  6evr|A|2018-10-21|S|+3.1;
  4cnv|A|2018-10-20|S|+3.1;
  4bcw|A|2018-10-20|S|+3.1;
  3s75|B|2018-10-20|S|+3.1;
  3dc3|A|2018-10-20|S|+3.1;
  1th9|A|2018-10-20|S|+3.1;
  4gl1|X|2018-10-20|S|+3.1;
  6fe2|A|2018-10-20|S|+3.1;
  4z0q|A|2018-10-20|S|+3.1;
  4qj0|A|2018-10-20|S|+3.1;
  4qk2|A|2018-10-20|S|+3.1;
  4bf1|A|2018-10-20|S|+3.1;
  3d92|A|2018-10-20|S|+3.1;
  2f14|A|2018-10-20|S|+3.1;
  5ogj|A|2018-10-20|S|+3.1;
  5nee|A|2018-10-20|S|+3.1;
  5ljq|A|2018-10-20|S|+3.1;
  4n0x|B|2018-10-20|S|+3.1;
  3mna|A|2018-10-20|S|+3.1;
  4knj|A|2018-10-20|S|+3.1;
  5bu6|A|2018-10-20|S|+3.1;
  4k0z|A|2018-10-20|S|+3.1;
  5fnl|A|2018-10-20|S|+3.1;
  5ehe|A|2018-10-20|S|+3.1;
  1j9w|A|2018-10-20|S|+3.1;
  3mzc|A|2018-10-20|S|+3.1;
  4k0s|A|2018-10-20|S|+3.1;
  5clu|A|2018-10-20|S|+3.1;
  4k0t|A|2018-10-20|S|+3.1;
  3w6h|A|2018-10-20|S|+3.1;
  5fnh|A|2018-10-20|S|+3.1;
  6eki|A|2018-10-20|S|+3.1;
  3igp|A|2018-10-20|S|+3.1;
  5ogp|A|2018-10-20|S|+3.1;
  4xix|A|2018-10-20|S|+3.1;
  4q09|A|2018-10-20|S|+3.1;
  4e3h|A|2018-10-20|S|+3.1;
  4m2w|A|2018-10-20|S|+3.1;
  4q08|A|2018-10-20|S|+3.1;
  4q07|A|2018-10-20|S|+3.1;
  3r17|B|2018-10-20|S|+3.1;
  2cbd|A|2018-10-20|S|+3.1;
  3f4x|A|2018-10-20|S|+3.1;
  2weh|A|2018-10-20|S|+3.1;
  2nnv|A|2018-10-20|S|+3.1;
  2fw4|A|2018-10-20|S|+3.1;
  3dc9|A|2018-10-20|S|+3.1;
  1zsc|A|2018-10-20|S|+3.1;
  2cba|A|2018-10-20|S|+3.1;
  1rj5|A|2018-10-20|S|+3.1;
  2eu3|A|2018-10-20|S|+3.1;
  3mnk|A|2018-10-20|S|+3.1;
  5jep|B|2018-10-20|S|+3.1;
  4qk3|A|2018-10-20|S|+3.1;
  5ekh|A|2018-10-20|S|+3.1;
  5eh5|A|2018-10-20|S|+3.1;
  4rn4|A|2018-10-20|S|+3.1;
  4pq7|A|2018-10-20|S|+3.1;
  3hlj|A|2018-10-20|S|+3.1;
  3oik|A|2018-10-20|S|+3.1;
  3mnj|A|2018-10-20|S|+3.1;
  2x7s|A|2018-10-20|S|+3.1;
  1hcb|A|2018-10-20|S|+3.1;
  3mni|A|2018-10-20|S|+3.1;
  2nng|A|2018-10-20|S|+3.1;
  6b5a|A|2018-10-20|S|+3.1;
  3w6i|A|2018-10-20|S|+3.1;
  2foq|A|2018-10-20|S|+3.1;
  5bu6|B|2018-10-20|S|+3.1;
  4q49|A|2018-10-20|S|+3.1;
  1yo0|A|2018-10-20|S|+3.1;
  4zwz|A|2018-10-20|S|+3.1;
  3ryv|B|2018-10-20|S|+3.1;
  4g7a|A|2018-10-20|S|+3.1;
  5txy|A|2018-10-20|S|+3.1;
  1te3|X|2018-10-20|S|+3.1;
  4k13|A|2018-10-20|S|+3.1;
  1hug|A|2018-10-20|S|+3.1;
  3rz1|B|2018-10-20|S|+3.1;
  3fe4|A|2018-10-20|S|+3.1;
  3bl1|A|2018-10-20|S|+3.1;
  3p44|A|2018-10-20|S|+3.1;
  4z1n|A|2018-10-20|S|+3.1;
  1lgd|A|2018-10-20|S|+3.1;
  1huh|A|2018-10-20|S|+3.1;
  5fnj|A|2018-10-20|S|+3.1;
  6equ|A|2018-10-20|S|+3.1;
  3mwo|A|2018-10-20|S|+3.1;
  5e2s|A|2018-10-20|S|+3.1;
  1cvb|A|2018-10-20|S|+3.1;
  4pyy|A|2018-10-20|S|+3.1;
  4dz7|A|2018-10-19|S|+3.1;
  4hey|A|2018-10-19|S|+3.1;
  2cab|A|2018-10-19|S|+3.1;
  5ehv|A|2018-10-19|S|+3.1;
  2vva|X|2018-10-19|S|+3.1;
  1bzm|A|2018-10-19|S|+3.1;
  4q6d|A|2018-10-19|S|+3.1;
  5aml|A|2018-10-19|S|+3.1;
  5eh8|A|2018-10-19|S|+3.1;
  5e2n|A|2018-10-19|S|+3.1;
  3dcs|A|2018-10-19|S|+3.1;
  5fl6|A|2018-10-19|S|+3.1;
  4lhi|A|2018-10-19|S|+3.1;
  3oyq|A|2018-10-19|S|+3.1;
  1eou|A|2018-10-19|S|+3.1;
  4zao|A|2018-10-19|S|+3.1;
  1oq5|A|2018-10-19|S|+3.1;
  5fni|A|2018-10-19|S|+3.1;
  4r5b|A|2018-10-19|S|+3.1;
  1ray|A|2018-10-19|S|+3.1;
  1cai|A|2018-10-19|S|+3.1;
  3m5t|A|2018-10-19|S|+3.1;
  4pxx|A|2018-10-19|S|+3.1;
  4e3d|A|2018-10-19|S|+3.1;
  3n2p|A|2018-10-19|S|+3.1;
  3t5z|A|2018-10-19|S|+3.1;
  1dcb|A|2018-10-19|S|+3.1;
  3s9t|A|2018-10-19|S|+3.1;
  6bcc|A|2018-10-19|S|+3.1;
  5dsj|A|2018-10-19|S|+3.1;
  5ti0|A|2018-10-19|S|+3.1;
  3hkq|A|2018-10-19|S|+3.1;
  5jn7|A|2018-10-19|S|+3.1;
  4qjw|A|2018-10-19|S|+3.1;
  1cay|A|2018-10-19|S|+3.1;
  4qsi|A|2018-10-19|S|+3.1;
  3sap|A|2018-10-19|S|+3.1;
  4qtl|A|2018-10-19|S|+3.1;
  3m2z|A|2018-10-19|S|+3.1;
  3p5l|A|2018-10-19|S|+3.1;
  4kni|A|2018-10-19|S|+3.1;
  5jg5|B|2018-10-19|S|+3.1;
  3sbh|A|2018-10-19|S|+3.1;
  1cal|A|2018-10-19|S|+3.1;
  5jn1|A|2018-10-19|S|+3.1;
  3ks3|A|2018-10-19|S|+3.1;
  4cnr|A|2018-10-19|S|+3.1;
  3mmf|A|2018-10-19|S|+3.1;
  3s71|B|2018-10-19|S|+3.1;
  3dcw|A|2018-10-19|S|+3.1;
  4idr|X|2018-10-19|S|+3.1;
  3hs4|A|2018-10-19|S|+3.1;
  6cjv|A|2018-10-19|S|+3.1;
  4rux|A|2018-10-19|S|+3.1;
  5jgt|B|2018-10-19|S|+3.1;
  5dsi|A|2018-10-19|S|+3.1;
  1rj6|A|2018-10-19|S|+3.1;
  5llc|A|2018-10-19|S|+3.1;
  3dd0|A|2018-10-19|S|+3.1;
  4mo8|A|2018-10-19|S|+3.1;
  3s78|B|2018-10-19|S|+3.1;
  3v3j|A|2018-10-19|S|+3.1;
  1g6v|A|2018-10-19|S|+3.1;
  2it4|A|2018-10-19|S|+3.1;
  5a6h|A|2018-10-19|S|+3.1;
  4g0c|A|2018-10-19|S|+3.1;
  5u0d|A|2018-10-19|S|+3.1;
  1v9i|C|2018-10-19|S|+3.1;
  1h9n|A|2018-10-19|S|+3.1;
  3dvd|A|2018-10-19|S|+3.1;
  4zx1|A|2018-10-19|S|+3.1;
  3hku|A|2018-10-19|S|+3.1;
  4ito|A|2018-10-19|S|+3.1;
  3v3h|B|2018-10-19|S|+3.1;
  5bnl|A|2018-10-19|S|+3.1;
  4ilx|A|2018-10-19|S|+3.1;
  2pov|A|2018-10-19|S|+3.1;
  5n1r|A|2018-10-19|S|+3.1;
  5jq0|A|2018-10-19|S|+3.1;
  2fmz|A|2018-10-19|S|+3.1;
  5cac|A|2018-10-19|S|+3.1;
  5flq|A|2018-10-19|S|+3.1;
  1t9n|A|2018-10-19|S|+3.1;
  5o07|A|2018-10-19|S|+3.1;
  3qyk|A|2018-10-19|S|+3.1;
  5n1s|A|2018-10-19|S|+3.1;
  5e2r|A|2018-10-19|S|+3.1;
  1caz|A|2018-10-19|S|+3.1;
  4rh2|A|2018-10-19|S|+3.1;
  1xq0|A|2018-10-19|S|+3.1;
  1fqr|A|2018-10-19|S|+3.1;
  5a25|A|2018-10-19|S|+3.1;
  3ni5|A|2018-10-19|S|+3.1;
  3k7k|A|2018-10-19|S|+3.1;
  1fr4|A|2018-10-19|S|+3.1;
  1cah|A|2018-10-19|S|+3.1;
  5jmz|A|2018-10-19|S|+3.1;
  3v3i|B|2018-10-19|S|+3.1;
  5amg|A|2018-10-19|S|+3.1;
  1uga|A|2018-10-19|S|+3.1;
  4hu1|A|2018-10-19|S|+3.1;
  5e2k|A|2018-10-19|S|+3.1;
  1zsb|A|2018-10-19|S|+3.1;
  4n16|A|2018-10-19|S|+3.1;
  3t82|A|2018-10-19|S|+3.1;
  4jsz|A|2018-10-19|S|+3.1;
  3k2f|A|2018-10-18|S|+3.1;
  3kig|A|2018-10-18|S|+3.1;
  3d9z|A|2018-10-18|S|+3.1;
  2q38|A|2018-10-18|S|+3.1;
  2osm|A|2018-10-18|S|+3.1;
  2nmx|A|2018-10-18|S|+3.1;
  3rld|A|2018-10-18|S|+3.1;
  6g9u|A|2018-10-18|S|+3.1;
  5wgp|A|2018-10-18|S|+3.1;
  5fl4|A|2018-10-18|S|+3.1;
  5ekj|A|2018-10-18|S|+3.1;
  4zwi|A|2018-10-18|S|+3.1;
  4zwy|A|2018-10-18|S|+3.1;
  3tvo|X|2018-10-18|S|+3.1;
  4jsw|A|2018-10-18|S|+3.1;
  3t83|A|2018-10-18|S|+3.1;
  4hf3|A|2018-10-18|S|+3.1;
  3lxe|A|2018-10-18|S|+3.1;
  3u7c|A|2018-10-18|S|+3.1;
  3u45|X|2018-10-18|S|+3.1;
  1xpz|A|2018-10-18|S|+3.1;
  3hkt|A|2018-10-18|S|+3.1;
  3p4v|A|2018-10-18|S|+3.1;
  3l14|A|2018-10-18|S|+3.1;
  1ugb|A|2018-10-18|S|+3.1;
  3oil|A|2018-10-18|S|+3.1;
  3dvc|A|2018-10-18|S|+3.1;
  1cnc|A|2018-10-18|S|+3.1;
  1lg6|A|2018-10-18|S|+3.1;
  3v3g|B|2018-10-18|S|+3.1;
  3hfp|A|2018-10-18|S|+3.1;
  2nn1|A|2018-10-18|S|+3.1;
  5dsm|A|2018-10-18|S|+3.1;
  5dsl|A|2018-10-18|S|+3.1;
  4m2v|A|2018-10-18|S|+3.1;
  3s77|B|2018-10-18|S|+3.1;
  5yui|A|2018-10-18|S|+3.1;
  5n0e|A|2018-10-18|S|+3.1;
  5llh|A|2018-10-18|S|+3.1;
  6d1m|A|2018-10-18|S|+3.1;
  1cvd|A|2018-10-18|S|+3.1;
  3m1w|A|2018-10-18|S|+3.1;
  5fng|A|2018-10-18|S|+3.1;
  3uyq|A|2018-10-18|S|+3.1;
  3m5s|A|2018-10-18|S|+3.1;
  2weo|A|2018-10-18|S|+3.1;
  2nn7|A|2018-10-18|S|+3.1;
  5ogo|A|2018-10-18|S|+3.1;
  4xfw|A|2018-10-18|S|+3.1;
  4zwx|A|2018-10-18|S|+3.1;
  4xiw|A|2018-10-18|S|+3.1;
  4riu|A|2018-10-18|S|+3.1;
  4cq0|A|2018-10-18|S|+3.1;
  4cnx|A|2018-10-18|S|+3.1;
  3dcc|A|2018-10-18|S|+3.1;
  1flj|A|2018-10-18|S|+3.1;
  2aw1|A|2018-10-18|S|+3.1;
  1crm|A|2018-10-18|S|+3.1;
  1fr7|A|2018-10-18|S|+3.1;
  3mnh|A|2018-10-18|S|+3.1;
  3p58|A|2018-10-18|S|+3.1;
  6bc9|A|2018-10-18|S|+3.1;
  5wg7|A|2018-10-18|S|+3.1;
  5mjn|A|2018-10-18|S|+3.1;
  5jg3|B|2018-10-18|S|+3.1;
  5jeg|B|2018-10-18|S|+3.1;
  5j8z|A|2018-10-18|S|+3.1;
  4y0j|A|2018-10-18|S|+3.1;
  5c8i|A|2018-10-18|S|+3.1;
  4zx0|A|2018-10-18|S|+3.1;
  4rfd|A|2018-10-18|S|+3.1;
  4q0l|A|2018-10-18|S|+3.1;
  4l5w|A|2018-10-18|S|+3.1;
  4cac|A|2018-10-18|S|+3.1;
  3tvn|X|2018-10-18|S|+3.1;
  4hez|A|2018-10-18|S|+3.1;
  3rg3|A|2018-10-18|S|+3.1;
  3t84|A|2018-10-18|S|+3.1;
  3oim|A|2018-10-18|S|+3.1;
  3rg4|A|2018-10-18|S|+3.1;
  3rge|A|2018-10-18|S|+3.1;
  3p3h|A|2018-10-18|S|+3.1;
  3oy0|A|2018-10-18|S|+3.1;
  2nxr|A|2018-10-18|S|+3.1;
  1tg3|A|2018-10-18|S|+3.1;
  2nxs|A|2018-10-18|S|+3.1;
  1yo1|A|2018-10-18|S|+3.1;
  1cvc|A|2018-10-18|S|+3.1;
  1hec|A|2018-10-18|S|+3.1;
  1teu|X|2018-10-18|S|+3.1;
  1tg9|A|2018-10-18|S|+3.1;
  1lzv|A|2018-10-18|S|+3.1;
  1rze|A|2018-10-18|S|+3.1;
  1kwr|A|2018-10-18|S|+3.1;
  1caj|A|2018-10-18|S|+3.1;
  6b4d|A|2018-10-18|S|+3.1;
  1cam|A|2018-10-18|S|+3.1;
  1cva|A|2018-10-18|S|+3.1;
  5n0d|A|2018-10-18|S|+3.1;
  5zxw|A|2018-10-18|S|+3.1;
  5lla|A|2018-10-18|S|+3.1;
  5ll5|A|2018-10-18|S|+3.1;
  5gmm|A|2018-10-18|S|+3.1;
  5e28|A|2018-10-18|S|+3.1;
  4yvy|A|2018-10-18|S|+3.1;
  4qjx|A|2018-10-17|S|+3.1;
  4knm|A|2018-10-17|S|+3.1;
  4kuw|A|2018-10-17|S|+3.1;
  3n4b|A|2018-10-17|S|+3.1;
  3mdz|A|2018-10-17|S|+3.1;
  1xeg|A|2018-10-17|S|+3.1;
  4qiy|A|2018-10-17|S|+3.1;
  4pzh|A|2018-10-17|S|+3.1;
  4q6e|A|2018-10-17|S|+3.1;
  4ht0|A|2018-10-17|S|+3.1;
  1ccu|A|2018-10-17|S|+3.1;
  3n3j|A|2018-10-17|S|+3.1;
  4ruy|A|2018-10-17|S|+3.1;
  6fag|A|2018-10-12|S|+3.1;
  6ex1|A|2018-10-12|S|+3.1;
  6faf|A|2018-10-12|S|+3.1;
  6f3b|A|2018-10-12|S|+3.1;
  2nwp|A|2018-10-05|S|+3.1;
  1h4n|A|2018-10-05|S|+3.1;
  3pjj|A|2018-10-04|S|+3.1;
  2nwy|A|2018-10-03|S|+3.1;
  1ca2|A|2018-10-03|S|+3.1;
  4kv0|A|2018-10-03|S|+3.1;
  4qjo|A|2018-10-03|S|+3.1;
  4qjp|A|2018-10-03|S|+3.1;
  4hba|A|2018-10-03|S|+3.1;
  4l5u|A|2018-10-03|S|+3.1;
  4kuv|A|2018-10-03|S|+3.1;
  5n24|A|2018-10-03|S|+3.1;
  4rfc|A|2018-10-03|S|+3.1;
  5sz6|A|2018-10-03|S|+3.1;
  4e49|A|2018-10-03|S|+3.1;
  2fou|A|2018-10-03|S|+3.1;
  2cbb|A|2018-10-03|S|+3.1;
  1jd0|A|2018-10-03|S|+3.1;
  3tmj|A|2018-10-02|S|+3.1;
  3b4f|A|2018-10-02|S|+3.1;
  3efi|A|2018-10-01|S|+3.1;
  3dbu|A|2018-10-01|S|+3.1;
  3kok|A|2018-10-01|S|+3.1;
  3eft|A|2018-10-01|S|+3.1;
  2weg|A|2018-10-01|S|+3.1;
  3ffp|X|2018-10-01|S|+3.1;
  3v5g|A|2018-10-01|S|+3.1;
  4cnw|A|2018-10-01|S|+3.1;
  3d0n|A|2018-10-01|S|+3.1;
  6h29|A|2018-09-30|S|+3.1;
  1bcd|A|2018-09-29|S|+3.1;
  1rza|A|2018-09-29|S|+3.1;
  1rzc|A|2018-09-29|S|+3.1;
  1rzd|A|2018-09-29|S|+3.1;
  1lg5|A|2018-09-29|S|+3.1;
  1tbt|X|2018-09-28|S|+3.1;
  1yo2|A|2018-09-28|S|+3.1;
  3d8w|A|2018-09-28|S|+3.1;
  3dd8|A|2018-09-28|S|+3.1;
  2wd2|A|2018-09-28|S|+3.1;
  2x7u|A|2018-09-28|S|+3.1;
  3pyk|A|2018-09-28|S|+3.1;
  3u47|A|2018-09-28|S|+3.1;
  4riv|A|2018-09-27|S|+3.1;
  5dsn|A|2018-09-26|S|+3.1;
  5dsk|A|2018-09-26|S|+3.1;
  5ljt|A|2018-09-26|S|+3.1;
Knot types Knot loop types pdb Title
S +31 S 3x +31 6ymbA Microed structure of human carbonic anhydrase ii
S +31 S 3x +31 6ufdA Carbonic anhydrase 2 with inhibitor (2z)-3-oxo-n-(4-sulfamoylphenyl)-2-[(thiophen-2-yl)methylidene]butanamide (11g/d7)
S +31 S 3x +31 6ufbA Carbonic anhydrase 2 with inhibitor (2z)-2-benzylidene-3-oxo-n-(4-sulfamoylphenyl)butanamide (11a/d1)
S +31 S 3x +31 6ufcA Carbonic anhydrase 2 with inhibitor (2z)-2-[(4-methoxyphenyl)methylidene]-3-oxo-n-(4-sulfamoylphenyl)butanamide (11d/d4)
S +31 S 3x +31 6klzA Human carbonic anhydrase ii v143i variant 00 atm co2
S +31 S 3x +31 6km0A Human carbonic anhydrase ii v143i variant 07 atm co2
S +31 S 3x +31 6km4A Human carbonic anhydrase ii native 07 atm co2
S +31 S 3x +31 6km6A Human carbonic anhydrase ii native 15 atm co2
S +31 S 3x +31 6wq4A Carbonic anhydrase ii complexed with 2-((2-cyanoethyl)(phenethyl)amino)-n-phenethyl-n-(4-sulfamoylphenethyl)acetamide
S +31 S 3x +31 6wq8A Carbonic anhydrase ii complexed with 3-((2-((furan-2-ylmethyl)(4-sulfamoylphenethyl)amino)-2-oxoethyl)(phenethyl)amino)propanoic acid
S +31 S 3x +31 6wq9A Carbonic anhydrase ii complexed with 3-((2-((naphthalen-2-ylmethyl)(4-sulfamoylphenethyl)amino)-2-oxoethyl)(phenethyl)amino)propanoic acid
S +31 S 3x +31 6t7uA Carborane inhibitor of carbonic anhydrase ix
S +31 S 3x +31 6t9zA Nidocarborane inhibitor of carbonic anhydrase ix
S +31 S 3x +31 6rmxA Human carbonic anhydrase ii mutant t199v bound by 2-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-3,5,6-trifluoro-4-[(2-hydroxyethyl)thio]benzenesulfonamide
S +31 S 3x +31 6otkA Carbonic anhydrase ix mimic complexed with ureido benzene sulfonamide mb10-596b
S +31 S 3x +31 6otoA Carbonic anhydrase ii complexed with ureic benzene sulfonamide mb9-561b
S +31 S 3x +31 6otqA Carbonic anhydrase ii complexed with ureic benzene sulfonamide mb10-596b
S +31 S 3x +31 6oubA Carbonic anhydrase ii complexed with benzene sulfonamide mb11-694b
S +31 S 3x +31 6otpA Carbonic anhydrase ii complexed with ureic benzene sulfonamide mb10-586b
S +31 S 3x +31 6ouhA Carbonic anhydrase ii mimic complexed with benzene sulfonamide mb11-710a
S +31 S 3x +31 6oudA Carbonic anhydrase ix mimic complexed with benzene sulfonamide mb11-694b
S +31 S 3x +31 6oufA Carbonic anhydrase ix mimic complexed with benzene sulfonamide mb11-707a
S +31 S 3x +31 6oukA Carbonic anhydrase ii complexed with benzene sulfonamide mb10-580b
S +31 S 3x +31 6ouiA Carbonic anhydrase ix mimic complexed with benzene sulfonamide mb11-710a
S +31 S 3x +31 6oujA Carbonic anhydrase ii complexed with benzene sulfonamide mb11-689a
S +31 S 3x +31 6oumA Carbonic anhydrase ix mimic complexed with benzene sulfonamide mb10-580b
S +31 S 3x +31 6rg3A Crystal structure of human carbonic anhydrase ii in complex with (r)-4-(2-benzylpiperazin-1-yl)benzenesulfonamide
S +31 S 3x +31 6rmyA Human carbonic anhydrase ii mutant t199v bound by 3-(cyclooctylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide
S +31 S 3x +31 6rhkA The crystal structure of human carbonic anhydrase ii in complex with 4-(3-benzylimidazolidine-1-carbonyl)benzenesulfonamide
S +31 S 3x +31 6rzxA Carbonic anhydrase caix mimic in complex with inhibitor fbsa
S +31 S 3x +31 6s03A Carbonic anhydrase caix mimic in complex with inhibitor i39lt379
S +31 S 3x +31 6sdsA Human carbonic anhydrase ii in complex with a sulfonamide inhibitor
S +31 S 3x +31 6r6jA Crystal structure of human carbonic anhydrase isozyme ii with 2-(benzenesulfonyl)-4-chloro-n-(2-hydroxyethyl)-5-sulfamoyl-benzamide
S +31 S 3x +31 6r71A Crystal structure of human carbonic anhydrase isozyme xii with 2-(benzenesulfonyl)-4-chloro-n-(2-hydroxyethyl)-5-sulfamoyl-benzamide
S +31 S 3x +31 6rm1A Human carbonic anhydrase ii in complex with fragment.
S +31 S 3x +31 6qutA Three dimensional structure of human carbonic anhydrase ix in complex with benzenesulfonamide
S +31 S 3x +31 6vkgA Human carbonic anhydrase ix mimic with epacadostat bound
S +31 S 3x +31 6ugpA Human carbonic anhydrase 2 complexed with sb4-206
S +31 S 3x +31 6ugqA Human carbonic anhydrase ix-mimic complexed with sb4-206
S +31 S 3x +31 6ugrA Human carbonic anhydrase 2 complexed with sb4-208
S +31 S 3x +31 6ugzA Human carbonic anhydrase ix-mimic complexed with sb4-208
S +31 S 3x +31 6ugoA Human carbonic anhydrase ix-mimic complexed with sb4-205
S +31 S 3x +31 6uh0A Human carbonic anhydrase 2 in complex with sb4-202
S +31 S 3x +31 6r6fA Crystal structure of human carbonic anhydrase isozyme ii with 4-chloro-2-cyclohexylsulfanyl-n-(2-hydroxyethyl)-5-sulfamoyl-benzamide
S +31 S 3x +31 6qn0A Three dimensional structure of human carbonic anhydrase xii in complex with benzenesulfonamide
S +31 S 3x +31 6qn2A Three dimensional structure of human carbonic anhydrase ix in complex with benzenesulfonamide
S +31 S 3x +31 6qn6A Three dimensional structure of human carbonic anhydrase ix in complex with benzenesulfonamide
S +31 S 3x +31 6u4qA Carbonic anhydrase 2 in complex with sb4197
S +31 S 3x +31 6u4tA Carbonic anhydrase 9 in complex with sb4197
S +31 S 3x +31 6nm0A Selective inhibition of carbonic anhydrase ix activity, using compound slc-149, displays limited anticancer effects in breast cancer cell lines
S +31 S 3x +31 6nlvA Selective inhibition of carbonic anhydrase ix activity, using compound slc-149, displays limited anticancer effects in breast cancer cell lines
S +31 S 3x +31 6i0lA Crystal structure of human carbonic anhydrase i in complex with the 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[2-(4-sulfamoylphenyl)ethyl]urea inhibitor
S +31 S 3x +31
4
6nj3A Thermostable variant of human carbonic anhydrase with ordered tetrazine 2.0 at site 233
S +31 S 3x +31
4
6nj6A Thermostable variant of human carbonic anhydrase with tetrazine 2.0 at site 186 reacted with stco in crystallo
S +31 S 3x +31 6ql2A Crystal structure of chimeric carbonic anhydrase vi with ethoxzolamide.
S +31 S 3x +31 6ql1A Crystal structure of chimeric carbonic anhydrase vi with 4-[(4,6-dimethylpyrimidin-2-yl)thio]-2,3,5,6-tetrafluorobenzenesulfonamide
S +31 S 3x +31 6hd2A Active-site conformational dynamics of carbonic anhydrase ii under native conditions: an nmr perspective
S +31 S 3x +31 6gxbA Carbonic anhydrase caix mimic in complex with inhibitor js13
S +31 S 3x +31 6gxeA Carbonic anhydrase caix mimic in complex with inhibitor js14
S +31 S 3x +31 6qfwA Human carbonic anhydrase ii with bound ircp* complex (cofactor 9) to generate an artificial transfer hydrogenase (athase)
S +31 S 3x +31 6qfuA Human carbonic anhydrase ii with bound ircp* complex (cofactor 7) to generate an artificial transfer hydrogenase (athase)
S +31 S 3x +31 6qfvA Human carbonic anhydrase ii with bound ircp* complex (cofactor 8) to generate an artificial transfer hydrogenase (athase)
S +31 S 3x +31 6qfxA Human carbonic anhydrase ii with bound ircp* complex (cofactor 10) to generate an artificial transfer hydrogenase (athase)
S +31 S 3x +31 6mbyA Carbonic anhydrase ii in complex with ferulic acid
S +31 S 3x +31 6g6tA Crystal structure of human carbonic anhydrase isozyme ii with n-butyl-2,4-dichloro-5-sulfamoyl-benzamide
S +31 S 3x +31 6g5uA Crystal structure of human carbonic anhydrase isozyme xiii with n-butyl-2,4-dichloro-5-sulfamoyl-benzamide
S +31 S 3x +31 6g5lA Crystal structure of human carbonic anhydrase isozyme xii with 4-chloro-2-(cyclohexylamino)-n-(2-hydroxyethyl)-5-sulfamoyl-benzamide
S +31 S 3x +31 6g7aA Crystal structure of human carbonic anhydrase isozyme xii 2-(benzylamino)-4-chloro-n-(2-hydroxyethyl)-5-sulfamoyl-benzamide
S +31 S 3x +31 6mbvA Carbonic anhydrase ii in complex with nicotinic acid
S +31 S 3x +31 6qebA Assessment of a large enzyme-drug complex by proton-detected solid-state nmr without deuteration
S +31 S 3x +31 6fjjA Joint neutron and x-ray crystal structure of human carbonic anhydrase ix mimic (saccharin).
S +31 S 3x +31 6fjiA Joint neutron and x-ray crystal structure of human carbonic anhydrase ix mimic (apo).
S +31 S 3x +31 6gcyA Joint neutron and x-ray crystal structure of human carbonic anhydrase ix mimic (saccharin-sugar conjugate complex)
S +31 S 3x +31 6h6sA Sad phasing on nickel-substituted human carbonic anhydrase ii
S +31 S 3x +31 6hwzA Selenols: a new class of carbonic anhydrase inhibitors
S +31 S 3x +31 6hx5A Selenols: a new class of carbonic anhydrase inhibitors
S +31 S 3x +31 6h33A The crystal structure of human carbonic anhydrase ii in complex with 4-(4-phenyl)-4-hydroxy-1-piperidine-1-carbonyl)benzenesulfonamide.
S +31 S 3x +31 6h34A The crystal structure of human carbonic anhydrase ii in complex with 4-[(4-fluorophenyl)methyl]-1-piperazinyl]benzenesulfonamide.
S +31 S 3x +31
4
6g3qA Crystal structure of human carbonic anhydrase ii in complex with the inhibitor famotidine
S +31 S 3x +31 6g3vA Crystal structure of human carbonic anhydrase i in complex with the inhibitor famotidine
S +31 S 3x +31 6eeoA Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines.
S +31 S 3x +31 6eczA Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines.
S +31 S 3x +31 6eehA Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines.
S +31 S 3x +31 6ebeA Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines.
S +31 S 3x +31 4yglA Naclo4--interactions between hofmeister anions and the binding pocket of a protein
S +31 S 3x +31 1ttmA Human carbonic anhydrase ii complexed with 667-coumate
S +31 S 3x +31 1azmA Drug-protein interactions: structure of sulfonamide drug complexed with human carbonic anhydrase i
S +31 S 3x +31 5neaA Crystal structure of human carbonic anhydrase ii in complex with the inhibitor 4-(2-methyl-1,3-oxazol-5-yl)benzene-1-sulfonammide
S +31 S 3x +31 6b59A Carbonic anhydrase ii in complex with nitrogenous base-bearing benezenesulfonamide
S +31 S 3x +31 5e2mA Crystal structure of human carbonic anhydrase isozyme i with 3-(cyclooctylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide
S +31 S 3x +31 4qsjA Crystal structure of human carbonic anhydrase isozyme xiii with 2-chloro-4-{[(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio]acetyl}benzenesulfonamide
S +31 S 3x +31 1rzbA X-ray analysis of metal substituted human carbonic anhydrase ii derivatives
S +31 S 3x +31 5ohhA Crystal structure of human carbonic anhydrase isozyme xiii with 2-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-3,5,6-trifluoro-4-[(2-hydroxyethyl)thio]benzenesulfonamide
S +31 S 3x +31 5n25A Crystal structure of human carbonic anhydrase ii in complex with the inhibitor 4-pyridin-3-yl-benzenesulfonamide
S +31 S 3x +31 4qizA Crystal structure of human carbonic anhydrase isozyme xiii with inhibitor
S +31 S 3x +31 6evrA Crystal structure of human carbonic anhydrase i in complex with the 4-(4 acetyl-3-benzylpiperazine-1 carbonyl)benzene-1-sulfonamide inhibitor
S +31 S 3x +31 4cnvA Surface residue engineering of bovine carbonic anhydrase to an extreme halophilic enzyme for potential application in postcombustion co2 capture
S +31 S 3x +31 4bcwA Carbonic anhydrase ix mimic in complex with (e)-2-(5-bromo-2- hydroxyphenyl)ethenesulfonic acid
S +31 S 3x +31 3s75B The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase
S +31 S 3x +31 3dc3A Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties
S +31 S 3x +31 1th9A Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii
S +31 S 3x +31 4gl1X Structure of h64a/n62l/n67l human carbonic anhydrase ii triple mutant
S +31 S 3x +31 6fe2A Three dimensional structure of human carbonic anhydrase ix
S +31 S 3x +31 4z0qA Carbonic anhydrase inhibitors: design and synthesis of new heteroaryl-n-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms (hca vii, hca ix, and hca xiv)
S +31 S 3x +31 4qj0A Crystal structure of catalytic domain of human carbonic anhydrase isozyme xii with inhibitor
S +31 S 3x +31 4qk2A Structural and catalytic effects of proline substitution and surface loop deletion in the extended active site of human carbonic anhydrase ii - e234p
S +31 S 3x +31 4bf1A Three dimensional structure of human carbonic anhydrase ii in complex with 5-(1-naphthalen-1-yl-1,2,3-triazol-4-yl)thiophene-2-sulfonamide
S +31 S 3x +31 3d92A Human carbonic anhydrase ii bound with substrate carbon dioxide
S +31 S 3x +31 2f14A Tne crystal structure of the human carbonic anhydrase ii in complex with a fluorescent inhibitor
S +31 S 3x +31 5ogjA Crystal structure of human carbonic anhydrase isozyme xiii with 2-(cyclooctylamino)-3,5,6-trifluoro-4-[(2-hydroxyethyl)thio]benzenesulfonamide
S +31 S 3x +31
4
5neeA Crystal structure of human carbonic anhydrase ii in complex with the inhibitor 5-[2-(morpholine-4-carbonyl)1,3-oxazol-5-yl)]thiophene-2-sulfonammide
S +31 S 3x +31 5ljqA Crystal structure of human carbonic anhydrase ii in complex with the 4-(4-(phenoxymethyl)-1h-1,2,3-triazol-1-yl)benzenesulfonamide inhibitor
S +31 S 3x +31 4n0xB Room temperature crystal structure of human carbonic anhydrase ii in complex with thiophene-2-sulfonamide
S +31 S 3x +31 3mnaA The crystal structure of human carbonic anhydrase ii in complex with a 1,3,5-triazine-substituted benzenesulfonamide inhibitor
S +31 S 3x +31 4knjA Crystal structure of human carbonic anhydrase isozyme ii with 2-chloro-4-[(pyrimidin-2-ylsulfanyl)acetyl]benzenesulfonamide
S +31 S 3x +31 5bu6A Structure of bpsb deaceylase domain from bordetella bronchiseptica
S +31 S 3x +31 4k0zA Structure of hcaix mimic (hcaii with 5 mutations in active site) in complex with methazolamide
S +31 S 3x +31 5fnlA Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination
S +31 S 3x +31 5eheA Crystal structure of human carbonic anhydrase isozyme ii with 3-(benzylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide
S +31 S 3x +31 1j9wA Solution structure of the cai michigan 1 variant
S +31 S 3x +31 3mzcA Human carbonic ahydrase ii in complex with a benzenesulfonamide inhibitor
S +31 S 3x +31 4k0sA Structure of hcaix mimic (hcaii with 5 mutations in active site) in complex with acetazolamide
S +31 S 3x +31 5cluA The crystal structure of the complex of hcaii with a saccharine derivative
S +31 S 3x +31 4k0tA Structure of hcaix mimic (hcaii with 5 mutations in active site) in complex with chlorzolamide
S +31 S 3x +31 3w6hA Crystal structure of 19f probe-labeled hcai in complex with acetazolamide
S +31 S 3x +31 5fnhA Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination
S +31 S 3x +31 6ekiA Structure of a hyperthermostable carbonic anhydrase identified from an active hydrothermal vent chimney
S +31 S 3x +31 3igpA Structure of inhibitor binding to carbonic anhydrase ii
S +31 S 3x +31 5ogpA Metalacarborane inhibitors of carbonic anhydrase ix
S +31 S 3x +31 4xixA Carbonic anhydrase cah3 from chlamydomonas reinhardtii in complex with phosphate.
S +31 S 3x +31 4q09A Crystal structure of chimeric carbonic anhydrase xii with inhibitor
S +31 S 3x +31 4e3hA Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors
S +31 S 3x +31 4m2wA Genetically engineered carbonic anhydrase ix in complex with dorzolamide
S +31 S 3x +31 4q08A Crystal structure of chimeric carbonic anhydrase xii with inhibitor
S +31 S 3x +31 4q07A Crystal structure of chimeric carbonic anhydrase ix with inhibitor
S +31 S 3x +31 3r17B Hcarbonic anhydrase ii bound to n-(2-fluoro.4-sulfamoylphenyl)-2-(thiophen-2-yl) acetamide
S +31 S 3x +31 2cbdA Structure of native and apo carbonic anhydrase ii and some of its anion-ligand complexes
S +31 S 3x +31 3f4xA Carbonic anhydrase inhibitors. comparison of chlorthalidone and indapamide x-ray crystal structures in adducts with isozyme ii: when three water molecules make the difference
S +31 S 3x +31 2wehA Thermodynamic optimisation of carbonic anhydrase fragment inhibitors
S +31 S 3x +31
4
2nnvA Structure of inhibitor binding to carbonic anhydrase ii
S +31 S 3x +31 2fw4A Carbonic anhydrase activators. the first x-ray crystallographic study of an activator of isoform i, structure with l-histidine.
S +31 S 3x +31 3dc9A Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties
S +31 S 3x +31 1zscA Carbonic anhydrase ii mutant e117q, holo form
S +31 S 3x +31 2cbaA Structure of native and apo carbonic anhydrase ii and some of its anion-ligand complexes
S +31 S 3x +31 1rj5A Crystal structure of the extracellular domain of murine carbonic anhydrase xiv
S +31 S 3x +31 2eu3A Human carbonic anhydrase ii in complex with novel inhibitors
S +31 S 3x +31 3mnkA Human carbonic anhydrase ii mutant k170h
S +31 S 3x +31 5jepB Human carbonic anhydrase ii (t199s) complexed with benzo[d]thiazole-2-sulfonamide
S +31 S 3x +31 4qk3A Structural and catalytic effects of proline substitution and surface loop deletion in the extended active site of human carbonic anhydrase ii - [delta]230-240
S +31 S 3x +31 5ekhA Human carbonic anhydrase ii complexed with a two-faced guest
How to cite
KnotProt | Interdisciplinary Laboratory of Biological Systems Modelling